Photofrin porfimer sodium regulatory update

Pinnacle submitted regulatory applications to Germany's Federal Institute for Drugs and Medical Devices and France's National Agency for the Safety of Medicine and Health Products for Photofrin porfimer sodium to treat unresectable advanced hilar cholangiocarcinoma. In France, Photofrin is approved to treat recurrent non-small cell bronchial cancer or esophageal cancer. In Germany, the product is approved to treat non-small cell endobronchial early carcinoma. ...